Authors and Disclosures
Shama Cash-Goldwasser, MD1–3, Sarah M. Labuda, MD1, David W. McCormick, MD1, Agam K. Rao, MD1, Andrea M. McCollum, PhD1, Brett W. Petersen, MD1, James Chodosh, MD4, Catherine M. Brown, DVM5, Suk Yin Chan-Colenbrander, MD6, Caitlin M. Dugdale, MD7, Michael Fischer, MD8, Amy Forrester9, Jayne Griffith, MPH3, Rachel Harold, MD10, Bruce W. Furness, MD1,10, Vivian Huang, MD11, Aaron R. Kaufman, MD12, Ellen Kitchell, MD13, Rachel Lee, DO14, Nicholas Lehnertz, MD3, Ruth Lynfield, MD3, Ketzela Jacobowitz Marsh, MD6, Lawrence C. Madoff, MD5, Nelson Nicolasora, MD15, Dharmendra Patel, MD16, Roberto Pineda II, MD12, Trey Powrzanas, FNP17, Afsoon Roberts, MD14, Maria Teresa Seville, MD16, Ami Shah, MD16, Joshua M. Wong, MD1, Jana M. Ritter, DVM1, Caroline A. Schrodt, MD1, Elliot Raizes, MD1, Sapna Bamrah Morris, MD1 and Jeremy A. W. Gold, MD1, CDC Monkeypox Clinical Escalations Team
1CDC Monkeypox Emergency Response Team; 2Epidemic Intelligence Service, CDC; 3Minnesota Department of Health; 4University of New Mexico School of Medicine, Albuquerque, New Mexico; 5Massachusetts Department of Public Health; 6University of Minnesota Medical Center, Minneapolis, Minnesota; 7Massachusetts General Hospital, Boston, Massachusetts; 8Texas Department of State Health Services; 9Dallas County Health and Human Services, Dallas, Texas; 10District of Columbia Department of Health, Washington, D.C.; 11Maricopa County Department of Health, Phoenix, Arizona; 12Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; 13University of Texas Southwestern Medical Center, Dallas, Texas; 14The George Washington University School of Medicine and Health Sciences, Washington, D.C.; 15Banner University Medical Center, University of Arizona, Phoenix, Arizona; 16Mayo Clinic Hospital, Phoenix, Arizona; 17Pueblo Family Physicians, Phoenix, Arizona.
Shama Cash-Goldwasser, firstname.lastname@example.org.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. James Chodosh is a consultant to the Food and Drug Administration, where he chairs an advisory committee for new ophthalmic medications. He also receives grant support from the National Institutes of Health (NIH) to study adenovirus keratitis. Caitlin M. Dugdale reports institutional support from the National Institute for Child Health and Human Development, NIH; Harvard University Center for AIDS Research; the Massachusetts General Hospital Executive Committee on Research; the International AIDS Vaccine Initiative; and the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Network, NIH. Aaron R. Kaufman reports support by a Heed Fellowship awarded by the Heed Ophthalmic Foundation. Roberto Pineda II reports royalties from Elsevier and consulting fees from Sanofi-Genzyme. No other potential conflicts of interest were disclosed.
CDC Monkeypox Clinical Escalations Team
Amimah Asif, CDC; Amy Beeson, CDC; Ramon Bhatia, CDC; Brian F. Borah, CDC; Kevin Chatham-Stevens, CDC; Rewa Choudhary, CDC; Eleanor Click, CDC; Thomas D. Filardo, CDC; Romeo R. Galang, CDC; Julia Haston, CDC; Sophia Hsu, CDC; Gurpreet Kaur, CDC; Anne Kimball, CDC; James T. Lee, CDC; Grace Marx, CDC; Janet McNicholl, CDC; Maureen J. Miller, CDC; Rebecca Noe, CDC; Siobhan O’Connor, CDC; Kevin O’Laughlin, CDC; Kia Padgett, CDC; Gail Thompson, CDC; Farrell Tobolowsky, CDC; Isaac Zulu, CDC.